As pharmaceutical manufacturers continue to advance their digital transformation strategies, a fundamental industry question remains: What capabilities must be in place to successfully deliver Pharma 4.0™?
The 2025 ISPE D/A/CH workshop on “Pharma’s Journey to Digital Manufacturing and Supply” united pharma leaders, technology experts, and regulatory authorities for three days of intense exchange on the digital transformation of our industry.
For the first time in ISPE Pharma 4.0™ Conference history, ISPE will dedicate an entire track for the 2025 ISPE Pharma 4.0™ Conference to Process Analytical Technology (PAT)—in recognition of how central it has...
Engineers know that data is only as valuable as the decisions it drives. The Data-Driven Manufacturing Excellence Solutions track at the 2025 ISPE Pharma 4.0™ Conference will showcase how pharma organizations...
The future of the pharmaceutical industry is being shaped by rapid advancements in digital technologies, automation, and data analytics. As we look ahead to 2025, the concept of Pharma 4.0™ is no longer just an aspirational vision—it is becoming a transformative reality that will redefine how medicines are developed, manufactured, and delivered to patients.
As the pharmaceutical industry navigates the complexities of digital transformation, the concept of Pharma 4.0™ emerges as a pivotal framework for integrating advanced technologies into business processes. The upcoming 2024 ISPE Pharma 4.0™ and Annex 1 Conference,...
